DiaMedica Therapeutics Inc.
DMAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401040
No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding DiaMedica Therapeutics Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 39 | 34 | −5 |
| Shares | 4.00M | 4.01M | +12.2K (+0.3%) |
| Value | $14.9M | $10.0M | −$4.88M (−32.7%) |
New holders (1)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citigroup Inc | 273 | $1.00K | 0.00% |
Sold out (6)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Manatuck Hill Partners, LLC | 144,800 | $540.0K |
| Anson Funds Management LP | 130,070 | $485.0K |
| Millennium Management LLC | 22,249 | $83.0K |
| Jump Financial, LLC | 21,800 | $81.0K |
| Marshall Wace, LLP | 10,031 | $38.0K |
| Simplex Trading, LLC | 6,350 | $23.0K |